Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Kidney Cancer”

139 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 139 results

Early research (Phase 1)Ended earlyNCT02595918
What this trial is testing

Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7+3 more
National Cancer Institute (NCI) 19
Not applicableStudy completedNCT04189835
What this trial is testing

EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients

Who this might be right for
EBV InfectionEBV ViremiaEpstein-Barr Virus Associated Lymphoproliferative Disorder+1 more
University of Aarhus 509
Testing effectiveness (Phase 2)Study completedNCT00556049
What this trial is testing

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaNeoplasm Metastases
Massachusetts General Hospital 72
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Large-scale testing (Phase 3)Ended earlyNCT01599754
What this trial is testing

Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients

Who this might be right for
Clear Cell Renal Carcinoma
SFJ Pharma Ltd. II 724
Testing effectiveness (Phase 2)Study completedNCT00335556
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Who this might be right for
Childhood Renal Cell CarcinomaClear Cell Renal Cell CarcinomaClear Cell Sarcoma of the Kidney+10 more
Children's Oncology Group 291
Testing effectiveness (Phase 2)Looking for participantsNCT07050771
What this trial is testing

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

Who this might be right for
Hepatopancreaticobiliary (HPB) MalignancyOvarian Cancer (OvCa)Kidney Cancers+1 more
The Methodist Hospital Research Institute 148
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Not applicableLooking for participantsNCT03702309
What this trial is testing

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

Who this might be right for
CancerBreast CancerLung Cancer+15 more
University Health Network, Toronto 2,500
Not applicableStudy completedNCT00075348
What this trial is testing

Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome

Who this might be right for
Kidney CancerVon Hippel-lindau Syndrome
National Institutes of Health Clinical Center (CC) 260
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07615348
What this trial is testing

CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Jinling Hospital, China 75
Testing effectiveness (Phase 2)Study completedNCT06138496
What this trial is testing

Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Sun Yat-sen University 39
Not applicableApproved For MarketingNCT00481559
What this trial is testing

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

Who this might be right for
Neoplasms
BTG International Inc.
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableStudy completedNCT06775158
What this trial is testing

Perioperative Myocardial and Renal Injury in Patients Undergoing Hepatic Resection

Who this might be right for
Liver NeoplasmKidney Injury, AcuteMyocardial Injury After Non-Cardiac Surgery
Istanbul Saglik Bilimleri University 128
Not applicableEnded earlyNCT00949052
What this trial is testing

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 1,000
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Not applicableStudy completedNCT04043975
What this trial is testing

Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan

Who this might be right for
Advanced or Metastatic Renal Cell Carcinoma
Bristol-Myers Squibb 286
Large-scale testing (Phase 3)Ended earlyNCT03024996
What this trial is testing

Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche 778
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Load More Results